The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme
Open Access
- 1 August 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (4), 548-552
- https://doi.org/10.1215/15228517-2008-020
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Methionine Synthase Polymorphism c.2756A>G Alters Susceptibility to Glioblastoma MultiformeCancer Epidemiology, Biomarkers & Prevention, 2006
- Genome-wide Hypomethylation in Human Glioblastomas Associated with Specific Copy Number Alteration, Methylenetetrahydrofolate Reductase Allele Status, and Increased ProliferationCancer Research, 2006
- Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma SurvivalCancer Research, 2006
- Genetic instability in cancer: Theory and experimentSeminars in Cancer Biology, 2005
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancerGynecologic Oncology, 2005
- Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young womenThe Journal of Nutritional Biochemistry, 2004
- Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?Cancer, 2003
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathwayThe Lancet, 1991